Erschienen in:
15.09.2017 | Letter to the Editor
Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches
verfasst von:
Dipl.-Phys. Dr. Christos Moustakis, Oliver Blanck, Fatemeh Ebrahimi, Mark ka heng Chan, Iris Ernst, Thomas Krieger, Marciana-Nona Duma, Markus Oechsner, Ute Ganswindt, Christian Heinz, Horst Alheit, Hilbert Blank, Ursula Nestle, Rolf Wiehle, Christine Kornhuber, Christian Ostheimer, Cordula Petersen, Gerhard Pollul, Wolfgang Baus, Georg Altenstein, Eric Beckers, Katrin Jurianz, Florian Sterzing, Matthias Kretschmer, Heinrich Seegenschmiedt, Torsten Maass, Stefan Droege, Ulrich Wolf, Juergen Schoeffler, Uwe Haverkamp, Hans Eich, Matthias Guckenberger
Erschienen in:
Strahlentherapie und Onkologie
|
Ausgabe 12/2017
Einloggen, um Zugang zu erhalten
Excerpt
We would like to thank Mancosu et al. for starting this valuable discussion about the Italian [
1] and the German [
2] planning study for lung stereotactic body radiation therapy (SBRT) and apologize for not having discussed this topic in depth in our original manuscript [
2]. We stated in our work that we were able to homogenize treatment planning using the DEGRO working group “Stereotactic Radiotherapy” guidelines [
3], but that still more effort is needed for homogenization of plan details such as target mean and critical structure dose. In the discussion we stated that in contrast to the Italian study [
1] tumor control probability (TCP) was homogenized with stricter planning target volume (PTV) constraints such as definitive maximum dose and volume covering 98% of the PTV to receive more than the prescribed dose of 3 × 15 Gy at the 65% isodose line. …
